Biotech IPOs surge to 13-year high
July 09, 2013 at 14:10 PM EDT
The biotech IPO window is officially open. Eleven second-quarter biotech initial public offerings totaling $1 billion — the strongest quarterly biotech market for venture-backed IPOs since third-quarter 2000 — fueled an overall surge in IPOs, according to the National Venture Capital Association and news and data company Thomson Reuters...
